The global whole genome and exome sequencing market is projected to reach $7,467.6 million by 2033 from $1,873.8 million in 2023, growing at a CAGR of 15.13% during the forecast period 2024-2033.
The Europe automated sample preparation market was valued at $381.3 million in 2023 and is expected to reach $925.1 million by 2033, growing at a CAGR of 9.27% between 2023 and 2033.
In an optimistic scenario, the market, valued at $8.7 million in 2024, is anticipated to grow at a CAGR of 15.43%, reaching $36.7 million by 2034.
The global mass spectrometry and chromatography in diagnostics market was valued at $743.1 million in 2023 and is expected to reach $1,863.8 million by 2033, growing at a CAGR of 9.92% during the forecast period 2024-2033.
The global ENT devices market was valued at $17.02 billion in 2023 and is expected to reach $30.82 billion by 2033, growing at a CAGR of 6.03% during the forecast period 2024-2033.
Need reports on an on-going basis? Do consider our annual subscription
The global hematologic malignancies testing market was valued at $3,546.3 million in 2023 and is expected to reach $13,509.5 million by 2033, growing at a CAGR of 14.09% during the forecast period 2024-2033.
The global liquid biopsy market was valued at $4,072.6 million in 2023 and is expected to reach $20,224.7 million by 2033, growing at a CAGR of 16.83% during the forecast period 2024-2033.
The global hereditary genetic testing market is projected to reach $81.95 billion by 2033 from $24.78 billion in 2023, growing at a CAGR of 12.73% during the forecast period 2024-2033.
The Asia-Pacific synthetic hormones market size was estimated at $2.41 billion in 2023 and is expected to reach $4.89 billion by 2033, growing at a CAGR of 7.34% during the forecast period 2023-2033.
The Asia-Pacific dental infections control market is projected to reach $627.7 million by 2033 from $300.5 million in 2023, growing at a CAGR of 7.64% during the forecast period 2023-2033.
The global metagenomics market was valued at $1,808.0 million in 2023 and is expected to reach $9,286.1 million by 2033, growing at a CAGR of 17.90% between 2024 and 2033.
The global surgical robotics simulation market was valued at $427.9 million in 2023 and is expected to reach $2,132.3 million by 2033, growing at a CAGR of 17.31% between the forecast period of 2024-2033.
The Europe highly potent API market is projected to reach $16.33 billion by 2033 from $5.98 billion in 2023, growing at a CAGR of 10.57% during the forecast period 2023-2033.
The global genome sequencing market was valued at $7.56 billion in 2023 and is expected to reach $30.23 billion by 2033, growing at a CAGR of 15.18% between 2024 and 2033.
The Europe synthetic hormones market size was estimated at $4.90 billion in 2023 and is expected to reach $10.53 billion by 2033, growing at a CAGR of 7.94% during the forecast period 2023-2033.
The Europe digital therapeutics market is projected to reach $13.91 billion by 2033 from $1.68 billion in 2023, growing at a CAGR of 23.54% during the forecast period 2023-2033.
Expected to grow from a base of $1.02 billion in 2024, the market is projected to experience a compound annual growth rate (CAGR) of 8.43%, reaching approximately $2.29 billion by 2034.
The global advanced wound dressing market is projected to reach $8,383.1 million by 2030 from $6,418.5 million in 2023, growing at a CAGR of 3.89% during the forecast period 2023-2030.
The Asia-Pacific genomic cancer panel and profiling market is expected to reach $4.78 billion by 2033 from $1.56 billion in 2023.
The global non-silicone foam dressings market is projected to reach $699.7 million by 2030 from $529.4 million in 2023, growing at a CAGR of 4.07% during the forecast period 2023-2030.
The global non-silver antimicrobial dressings market is projected to reach $565.8 million by 2030 from $437.2 million in 2023, growing at a CAGR of 3.75% during the forecast period 2023-2030.
The global organ-on-chip market is projected to reach $3,596.3 million by 2033 from $109.9 million in 2023, growing at a CAGR of 42.09% during the forecast period 2024-2033.
The Europe interventional imaging market is projected to reach $4.23 billion by 2033 from $2.23 billion in 2023, growing at a CAGR of 6.62% during the forecast period 2023-2033.
The global wound therapy devices market is projected to reach $6,473.5 million by 2030 from $4,781.7 million in 2023, growing at a CAGR of 4.42% during the forecast period 2023-2030.
The global wound skin substitutes market is projected to reach $2,062.6 million by 2030 from $1,255.5 million in 2023, growing at a CAGR of 7.35% during the forecast period 2023-2030.
The global PMS and menstrual health supplements market was valued at $21.68 billion in 2023 and is expected to reach $37.23 billion by 2033, growing at a CAGR of 5.45% between 2023 and 2033.
The global medical tape and bandages market is projected to reach $4,490.8 million by 2030 from $3,750.5 million in 2023, growing at a CAGR of 2.61% during the forecast period 2023-2030.
The global silicone scar dressing market is projected to reach $495.6 million by 2030 from $318.9 million in 2023, growing at a CAGR of 6.50% during the forecast period 2023-2030.
The Europe MRD testing market is projected to reach $1,744.0 million by 2033 from $424.0 million in 2023, growing at a CAGR of 15.19% during the forecast period 2023-2033.
The global dental implants and prosthetics market has been valued at $11.44 billion in 2024 and is expected to grow at a CAGR of 7.09% to reach $22.70 billion by 2034
The global surgical/sharp debridement market was valued at $209.7 million in 2023 and is anticipated to reach $295.9 million by 2030, witnessing a CAGR of 5.05% during the forecast period 2023-2030.
The global wound electrical stimulation devices market was valued at $207.5 million in 2023 and is anticipated to reach $328.4 million by 2030, witnessing a CAGR of 6.78% during the forecast period 2023-2030.
Considering the optimistic scenario, the global medical robots market has been valued at $16.39 billion in 2024 and is expected to grow at a CAGR of 18.31%.
The global wound biologics market was valued at $1,974.7 million in 2023 and is anticipated to reach $3,321.5 million by 2030, witnessing a CAGR of 7.71% during the forecast period 2023-2030.
The global hyperbaric oxygen therapy market was valued at $480.0 million in 2023 and is anticipated to reach $734.1 million by 2030, witnessing a CAGR of 6.26% during the forecast period 2023-2030.
The global silver antimicrobial dressings market was valued at $1,014.0 million in 2023 and is anticipated to reach $1,256.3 million by 2030, witnessing a CAGR of 3.11% during the forecast period 2023-2030.
The global enzymatic debridement market was valued at $553.2 million in 2023 and is anticipated to reach $826.1 million by 2030, witnessing a CAGR of 5.90% during the forecast period 2023-2030.
The global hydrocolloid dressings market was valued at $816.6 million in 2023 and is anticipated to reach $1,029.9 million by 2030, witnessing a CAGR of 3.37% during the forecast period 2023-2030.
The global silicone foam dressings market was valued at $1,263.4 million in 2023 and is anticipated to reach $1,731.2 million by 2030, witnessing a CAGR of 4.60% during the forecast period 2023-2030.
The global offloading devices market was valued at $1,207.5 million in 2023 and is anticipated to reach $1,546.6 million by 2030, witnessing a CAGR of 3.60% during the forecast period 2023-2030.
The global compression bandages market was valued at $769.4 million in 2023 and is anticipated to reach $1,019.3 million by 2030, witnessing a CAGR of 4.10% during the forecast period 2023-2030.
The Europe DNA/RNA sample extraction and isolation market was valued at $629.0 million in 2023 and is expected to reach $1,236.2 million by 2033, growing at a CAGR of 6.99% between 2023 and 2033.
The global mechanical debridement market was valued at $363.6 million in 2023 and is anticipated to reach $536.0 million by 2030, witnessing a CAGR of 5.70% during the forecast period 2023-2030.
The global wound growth factors market was valued at $421.7 million in 2023 and is anticipated to reach $750.7 million by 2030, witnessing a CAGR of 8.59% during the forecast period 2023-2030.
The global hydrogel dressings market was valued at $191.7 million in 2023 and is anticipated to reach $260.0 million by 2030, witnessing a CAGR of 4.45% during the forecast period 2023-2030.
The global negative pressure wound therapy (NPWT) market was valued at $2,117.3 million in 2023 and is anticipated to reach $2,845.1 million by 2030, witnessing a CAGR of 4.31% during the forecast period 2023-2030.
The global ultrasonic debridement market was valued at $145.6 million in 2023 and is anticipated to reach $240.6 million by 2030, witnessing a CAGR of 7.43% during the forecast period 2023-2030.
The global contact layer dressings market was valued at $557.2 million in 2023 and is anticipated to reach $712.6 million by 2030, witnessing a CAGR of 3.58% during the forecast period 2023-2030.
The global alginate dressings market was valued at $393.1 million in 2023 and is anticipated to reach $519.8 million by 2030, witnessing a CAGR of 4.07% during the forecast period 2023-2030.
The global collagen dressings market was valued at $477.2 million in 2023 and is anticipated to reach $613.1 million by 2030, witnessing a CAGR of 3.65% during the forecast period 2023-2030.
The global film dressings market was valued at $525.9 million in 2023 and is anticipated to reach $695.9 million by 2030, witnessing a CAGR of 4.08% during the forecast period 2023-2030.
The global superabsorbent dressings market was valued at $212.8 million in 2023 and is anticipated to reach $298.8 million by 2030, witnessing a CAGR of 4.97% during the forecast period 2023-2030.
The Europe scar management market was valued at $238.5 million in 2023 and is anticipated to reach $351.0 million by 2030, witnessing a CAGR of 5.67% during the forecast period 2023-2030.
The Asia-Pacific wearable patches market was valued at $2,268.6 million in 2023 and is expected to reach $5,300.6 million by 2031, growing at a CAGR of 11.19% between 2023 and 2031.
The global robotic surgery consumables market was valued at $4.87 billion in 2023 and is expected to reach $15.61 billion by 2033, growing at a CAGR of 12.34% during the forecast period 2023-2033.
The global targeted sequencing market was valued at $3,479.8 million in 2023 and is expected to reach $10,987.4 million by 2033, growing at a CAGR of 12.28% between 2024 and 2033.
The global computed tomography market is projected to reach $10.21 billion by 2033 from $6.17 billion in 2023, growing at a CAGR of 5.22% during the forecast period 2024-2033.
The global precision medicine software market was valued at $1,824.9 million in 2023 and is expected to reach $5,696.3 million by 2033, growing at a CAGR of 12.13% between 2024 and 2033.
The global NIPT market was valued at $3,350.4 million in 2023 and is expected to reach $12,870.9 million by 2033, registering a CAGR of 14.41% during the forecast period 2023-2033.
The global wound debridement market was valued at $1,272.0 million in 2023 and is expected to reach $1,898.6 million by 2030, growing at a CAGR of 5.89% during the forecast period 2023-2030.
The global microarray analysis market was valued at $5,357.9 million in 2023 and is expected to reach $10,112.4 million by 2033, growing at a CAGR of 6.56% during the forecast period 2023-2033.
The global companion diagnostics market was valued at $3,762.0 million in 2023 and is expected to reach $12,498.7 million by 2033, growing at a CAGR of 12.76% between 2023 and 2033.
The global HPLC market was estimated at $5.23 billion in 2023 and is expected to reach $8.22 billion by 2033, growing at a CAGR of 4.61% during the forecast period 2023-2033.
The global aseptic connectors market was valued at $746.7 million in 2023 and is expected to reach $1,907.0 million by 2033, growing at a CAGR of 9.83% between 2023 and 2033.
The Europe wound cleanser market was valued at $460.7 million in 2023 and is expected to reach $564.8 million by 2030, growing at a CAGR of 2.95% between 2023 and 2030.
The Europe rare disease genetic testing market was valued at $1.16 billion in 2023 and is anticipated to reach $4.17 billion by 2033, witnessing a CAGR of 13.60% during the forecast period 2023-2033.
The global colorectal cancer screening and diagnostics market was valued at $38,540.7 million in 2023 and is expected to reach $48,710.9 million by 2033, growing at a CAGR of 2.37% during the forecast period 2023-2033.
The global nucleic acid sample preparation market is projected to reach $5,615.9 million by 2033 from $2,922.8 million in 2023, growing at a CAGR of 6.75% during the forecast period 2023-2033.
The MRD testing market was valued at $1.47 billion in 2022 and is expected to reach $6.67 billion by 2033, growing at a CAGR of 14.81% between 2023 and 2033.
The global digital diagnostics market is projected to reach $8,319.2 million by 2033 from $1,431.7 million in 2023, growing at a CAGR of 19.24% during the forecast period 2023-2033.
The Asia-Pacific next-generation IVD market was valued at $21.43 billion in 2023 and is expected to reach $42.35 billion by 2033, growing at a CAGR of 7.05% between 2023 and 2033.
The Asia-Pacific Next-Generation Breast Cancer Diagnostic and Screening Market is projected to reach $1,779.4 Million by 2032 from $554.3 Million in 2023, growing at a CAGR of 13.84% during the forecast period 2023-2032.
In 2023, the Asia-Pacific organ transplant diagnostics market was valued at $1.25 billion and is expected to reach $3.45 billion by 2033, with a CAGR of 10.73% during the forecast period 2023-2033.
The Europe contrast media agent and injector system market was valued at $2,141.5 million in 2022 and is expected to reach $2,740.6 million by 2026, growing at a CAGR of 6.36% during the forecast period 2022-2026.
The global automated sample preparation market was valued at $1,431.9 million in 2023 and is expected to reach $3,730.5 million by 2033, growing at a CAGR of 10.05% between 2023 and 2033.
The Asia-Pacific MRD testing market is projected to reach $1.33 billion by 2033 from $0.30 billion in 2023, growing at a CAGR of 16.06% during the forecast period 2023-2033.
The Europe cell and gene therapy manufacturing Quality Control (QC) market is expected to reach $2,545.6 million by 2033 from $534.3 million in 2023 at a CAGR of 16.90% during the forecast period 2023-2033.
The global digital surgery technologies market is projected to reach $12,997.3 million by 2033 from $783.2 million in 2023, growing at a CAGR of 32.43% during the forecast period 2023-2033.
The global continuous bioprocessing market was valued at $250.1 million in 2023 and is expected to reach $1,639.1 million by 2033, growing at a CAGR of 20.68% between 2023 and 2033.
In 2023, the Europe functional genomics market was valued at $3.01 billion, and it is expected to reach $10.69 billion by 2033.
The Asia-Pacific single-cell multi-omics market is projected to reach $1.85 billion by 2033 from $0.30 billion in 2023, growing at a CAGR of 20.00% during the forecast period 2023-2033.
The Europe nucleic acid therapeutics CDMO market was valued at $1.27 billion in 2023 and is expected to reach $3.88 billion by 2033, growing at a CAGR of 11.80% during the forecast period 2023-2033.
The Asia-Pacific gene editing technologies market was valued at $0.49 billion in 2023 and is anticipated to reach $5.05 billion by 2032, witnessing a CAGR of 29.64% during the forecast period 2023-2032.
The global DNA methylation detection technology market was valued at $2.80 billion in 2023 and is expected to reach $12.32 billion by 2033, growing at a CAGR of 15.96% between 2023 and 2033.
The Asia-Pacific cell-based assay market was valued at $4.05 billion in 2023 and is anticipated to reach $9.19 billion by 2032, witnessing a CAGR of 9.53% during the forecast period 2023-2032.
The Europe multicancer screening market is projected to reach $2.09 billion by 2032 from $0.55 billion in 2023, growing at a CAGR of 15.93% during the forecast period 2023-2032.
The global protein expression market was valued at $2,393.0 million in 2023 and is expected to reach $6,963.6 million by 2033, growing at a CAGR of 11.27% between 2023 and 2033.
The market size was estimated at $19.40 billion in 2023 and is expected to reach $38.08 billion by 2033, growing at a CAGR of 6.98% during the forecast period 2023-2033.
The global dental infections control market is projected to reach $2,445.4 million by 2033 from $1,292.4 million in 2023, growing at a CAGR of 6.59% during the forecast period 2023-2033.
The global clinical biomarkers market was valued at $24.80 billion in 2023 and is expected to reach $53.20 billion by 2033, growing at a CAGR of 7.93% between 2023 and 2033.
The global highly potent API market is projected to reach $84.20 billion by 2033 from $27.44 billion in 2023, growing at a CAGR of 11.86% during the forecast period 2023-2033.
The Europe gene fusion testing market was valued at $71.4 million in 2023 and is anticipated to reach $248.2 million by 2033, witnessing a CAGR of 13.27% during the forecast period 2023-2033.
The market size is anticipated to be $0.06 billion in 2026 and is expected to reach $7.72 billion by 2040, growing at a CAGR of 41.55% during the forecast period 2026-2040.
The Korea centrifugation market was valued at $46.1 million in 2023 and is expected to reach $80.6 million by 2033, growing at a CAGR of 5.75% between 2023 and 2033.
The Asia-Pacific cell and gene therapy manufacturing QC market was valued at $426.3 million in 2023 and is expected to reach $2,233.6 million by 2033.
The Asia-Pacific NGS data storage market is projected to reach $1,284.3 million by 2033 from $207.5 million in 2023, growing at a CAGR of 19.99% during the forecast period 2023-2033.
The global veterinary vaccine market is projected to reach $19.86 billion by 2033 from $9.82 billion in 2023, growing at a CAGR of 7.30% during the forecast period 2023-2033.
The Europe minimally invasive spine technologies market was valued at $691.1 million in 2022 and is anticipated to reach $2,116.5 million by 2032, witnessing a CAGR of 11.84% during the forecast period 2022-2032.
The Europe autonomous surgical robotics market was valued at $432.7 million in 2023 and is expected to reach $2,157.0 million by the end of 2033.
As of 2023, the Europe genomic cancer panel and profiling market was valued at $2.64 billion and is expected to attain a value of $6.50 billion in 2033.
The Asia-Pacific interventional imaging market was valued at $1.11 billion in 2023 and is expected to reach $2.44 billion by the end of 2033, growing at a CAGR of 8.18% during the forecast period 2023-2033.
The sleep apnea oral appliances market report presents an extensive overview of the industry, encompassing both qualitative and quantitative data.
This report aims to provide a comprehensive analysis of the single use assemblies market, focusing on current unmet needs, trends, challenges and opportunities shaping the industry landscape.
The global healthcare cloud computing market report provides a comprehensive analysis of the current trends, market size, growth drivers, and challenges in the healthcare cloud computing industry.
The global elderly care services market report provides a comprehensive analysis of the industry, highlighting key trends, market dynamics, and growth opportunities.
Asia-Pacific Advanced Dental Digital and Robotics Solutions Market: Analysis and Forecast, 2023-2032
In 2023, the Asia-Pacific advanced dental digital and robotics solutions market was valued at $0.8 billion and is expected to reach $2.1 billion by 2032.
The global bioprocess bags and containers market report offers a detailed assessment of market segments, including product type and end user, elucidating their respective market shares and growth prospects.
The bioprocessing probes and sensors market report provides a comprehensive analysis of the industry, highlighting key trends, market dynamics, and growth opportunities.
The report delves into various factors influencing the industry, including recent trends, recent advancements, and regulatory aspects.
This comprehensive report provides a detailed analysis of market trends, key players, and growth opportunities within the veterinary equipment and supplies sector.
The Asia-Pacific rare disease genetic testing market was valued at $0.51 billion in 2022 and is expected to reach $2.40 billion by 2033, witnessing a CAGR of 15.25% during the forecast period 2023-2033.
The Europe acute care syndromic testing market was valued at $0.90 billion in 2022 and is expected to reach $2.32 billion by 2033, growing at a CAGR of 8.95% between 2023 and 2033.
The Europe cardiac AI monitoring and diagnostics market was valued at $275.6 million in 2022 and is anticipated to reach $3,199.9 million by 2032, witnessing a CAGR of 28.09% during the forecast period 2023-2032.
The Europe EV-based liquid biopsy market was valued at $18.88 million in 2022 and is anticipated to reach $115.34 million by 2032.
The global pen needle market report provides a comprehensive analysis of the industry, highlighting key trends, market dynamics, and growth opportunities.
The report offer a comprehensive overview of the microcarriers market, highlighting key trends, growth drivers, challenges, and opportunities shaping this dynamic industry.
The report contains crucial statistics concerning the status of prominent players in the cystatin C assay market, highlighting key trends and potential opportunities within the market.
The Asia-Pacific wound cleanser market was valued at $547.4 million in 2022 and is expected to reach $754.6 million by 2030, growing at a CAGR of 4.10% during the forecast period 2023-2030.
The Asia-Pacific laboratory automation market was valued at $1.17 billion in 2022 and is expected to reach $3.69 billion by the end of 2033, registering a CAGR of 11.03% during the forecast period 2023-2033.
The remote patient monitoring (RPM) market report provides a comprehensive analysis of the global market for remote patient monitoring technologies and services.
The immunoassay plays a pivotal role in diagnostics and therapeutic applications, encompassing a wide range of techniques such as ELISA, western blotting, radioimmunoassay, and rapid tests.
The Europe wearable patches market was valued at $3.03 billion in 2022 and is expected to reach $7.85 billion by 2031, growing at a CAGR of 10.29% between 2023 and 2031.
The global digital therapeutics market is projected to reach $46.80 billion by 2033 from $4.90 billion in 2022, growing at a CAGR of 22.93% during the forecast period 2023-2033.
The hemostats market report provides a comprehensive analysis of presents an extensive overview of the industry, encompassing both qualitative and quantitative data.
The global fetal and neonatal care equipment market report provides a comprehensive analysis of the industry, highlighting key trends, market dynamics, and growth opportunities.
Global Restorative Dentistry Market rising prevalence of oral health diseases, a heightened emphasis on aesthetics, and the growing trend of dental tourism in emerging markets.
The study evaluates the competitive landscape, profiling leading players, and assessing their strategies to gain a competitive edge.
The MEA cosmeceuticals market is experiencing robust growth due to several key factors. Firstly, there is a rising awareness and demand for skincare and beauty products among the population in the region.
The global antibody therapeutic market occupies a pivotal role within the biopharmaceutical and life sciences sectors, dedicated to the manufacturing, advancement, and commercialization of antibodies with diverse applications in medical and research domains.
This report aims to provide a comprehensive analysis of the ALL market, focusing on current unmet needs, trends, challenges and opportunities shaping the industry landscape.
The global tympanometer market research report offers a detailed insight into the market, providing an in-depth analysis of the market's current prospects.
The global CRRT market is witnessing significant growth, driven by the increasing prevalence of acute kidney injuries (AKI) and the rising demand for advanced renal care solutions.
This comprehensive report provides a detailed analysis of market trends, key players, and growth opportunities within the bariatric surgery sector.
Global bioprocessing validation market report serves as a valuable resource for industry participants, investors, and decision-makers seeking to navigate the dynamic landscape.
ELISpot and FluoroSpot Assay Market play a crucial role in immunological research and diagnostics, and this report projects the market landscape on a global scale.
The respiratory diagnostics market is a rapidly growing focused on the diagnosis and monitoring of various respiratory conditions.
The market is expected to grow at a CAGR of 15.43% during the forecast period 2023-2032 and attain a value of $80.05 billion by 2032.
The global market for urological devices plays a crucial role in diagnosing and treating a diverse range of urological conditions, including urolithiasis, urethral malignancies, bladder disorders, and kidney diseases.
The report constitutes an extensive study of GCC Veterinary Laboratories industry.
This comprehensive report offers an in-depth analysis of the Global Surgical Sutures Market, covering key trends, market dynamics, competitive landscape, and future projections.
The global pharmaceutical excipients market is witnessing robust growth due to the increasing demand for pharmaceutical formulations and rising focus on drug delivery systems.
The market is expected to grow at a CAGR of 11.31% during the forecast period 2023-2033 and attain a value of $36.82 billion by 2033.
The market's expansion is driven by factors such as increasing incidence of cancer, continuous technological advancements such as the development of MRI linear accelerators, proton therapy, and the introduction of treatment planning software that integrates with imaging data.
The transdermal patches market encompasses a dynamic sector within the pharmaceutical industry that focuses on the development, manufacturing, and distribution of patches designed for drug delivery through the skin.
Digital health refers to the integration of digital technologies, such as software, mobile devices, telemedicine, wearable sensors, artificial intelligence (AI), and other technological tools, into healthcare and medicine.
The global genomic cancer panel and profiling market is expected to reach $26.59 billion by 2033 from $9.90 billion in 2022.
The report highlights the transformative impact of biologic therapies on individuals suffering from chronic inflammatory diseases, showcasing how these treatments have not only reduced dependency on health and welfare systems but also improved patients' physical function, enabling them to live more independently.
The Europe biomanufacturing viral detection and quantification market was valued at $137.3 million in 2022 and is anticipated to reach $345.9 million by 2032.
The global autonomous surgical robotics market was valued at $1.81 billion in 2022 and is anticipated to reach $11.07 billion by 2033.
As of 2022, the Asia-Pacific multicancer screening market was valued at $0.27 billion and is expected to attain a value of $1.40 billion by 2032.
The Asia-Pacific medical X-Ray detectors market was valued at $508.2 million in 2022 and is anticipated to grow to $913.7 million by the end of 2032.
The global interventional imaging market is projected to reach $16.93 billion by 2033 from $8.66 billion in 2022, growing at a CAGR of 6.71% during the forecast period 2023-2033.
The Europe nucleic acid sample preparation market is projected to reach $3,356.7 million by 2032 from $1,307.4 million in 2022, growing at a CAGR of 9.89% during the forecast period 2022-2032.
The Asia-Pacific surgical robotics market was valued at $1,637.6 million in 2022 and is expected to reach $8,068.7 million by the end of 2032, registering a CAGR of 17.29% during the forecast period 2022-2032.
The global advanced dental digital and robotics solutions market was valued at $3.82 billion in 2022 and is anticipated to reach $8.99 million by 2032, witnessing a CAGR of 9.15% during the forecast period 2023-2032.
The Asia-Pacific cell and gene therapy biomanufacturing market was valued at $1.96 billion in 2022 and is expected to reach $8.60 billion by the end of 2031, growing at a CAGR of 17.88% during the forecast period 2022-2031.
Asia-Pacific nucleic acid therapeutics CDMO market was valued at $0.97 billion in 2022 and is expected to reach $4.04 billion by 2033.
In 2022, the India emerging infectious disease diagnostics market was valued at $339.1 million and is expected to grow at a CAGR of 10.29% during the forecast period 2023-2033 to register a value of $982.7 million in 2033.
The global medical and surgical drainage system market was valued at $2,468.7 million in 2022 and is expected to reach $3,073.4 million by 2027, growing at a CAGR of 4.86% between 2023 and 2027.
The global biopsy devices market is projected to reach $11,869.4 million by 2027 from $5,852.8 million in 2022, growing at a CAGR of 15.15% during the forecast period 2023-2027.
The market is expected to grow at a CAGR of 7.07% during the forecast period 2023-2033 and attain a value of $4.79 billion by 2033.
The global wearable patches market was valued at $10,462.4 million in 2022 and is expected to reach $26,892.7 million by 2031, growing at a CAGR of 10.19% between 2023 and 2031.
The global scar management market was valued at $1,040.1 million in 2022 and is anticipated to reach $1,594.4 million by 2030, witnessing a CAGR of 5.53% during the forecast period 2023-2030.
The global wound cleanser market was valued at $1,873.4 million in 2022 and is expected to reach $2,434.3 million by 2030, growing at a CAGR of 3.34% between 2023 and 2030.
The global laboratory automation market was valued at $9.17 billion in 2022 and is anticipated to reach $24.84 billion by 2033, witnessing a CAGR of 9.57% during the forecast period 2023-2033.
The global gene fusion testing market was valued at $255.3 million in 2022 and is anticipated to reach $897.6 million by 2033, witnessing a CAGR of 12.25% during the forecast period 2023-2033.
The global cell and gene therapy biomanufacturing CDMO market - focused on AAV was valued at $231.3 million in 2022 and is anticipated to reach $2,566.6 million by 2033, witnessing a CAGR of 24.61% during the forecast period 2023-2033.
The global rare disease genetic testing market was valued at $4.11 billion in 2022 and is anticipated to reach $16.69 billion by 2033, witnessing a CAGR of 13.69% during the forecast period 2023-2033.
The global cardiac AI monitoring and diagnostics market was valued at $1,010.5 million in 2022 and is anticipated to reach $10,666.5 million by 2032, witnessing a CAGR of 26.88% during the forecast period 2023-2032.
The next-generation IVD market was valued at $86.21 billion in 2022 and is expected to reach $152.62 billion by 2033, growing at a CAGR of 5.41% between 2023 and 2033.
The global emerging infectious disease diagnostics market was valued at $19.56 billion in 2022 and is expected to reach $37.21 billion by 2033, growing at a CAGR of 6.19% between 2023 and 2033.
The global EV-based liquid biopsy market was valued at $78.22 million in 2022 and is anticipated to reach $455.53 million by 2032, witnessing a CAGR of 19.73% during the forecast period 2023-2032.
The global acute care syndromic testing market was valued at $3.14 billion in 2022 and is expected to reach $8.44 billion by 2033, growing at a CAGR of 9.43% between 2023 and 2033.
The global biomanufacturing viral detection and quantification market was valued at $474.3 million in 2022 and is anticipated to reach $1,149.7 million by 2032, witnessing a CAGR of 9.37% during the forecast period 2023-2032.
The global cell and gene therapy manufacturing QC market was valued at $1.95 billion in 2022 and is anticipated to reach $10.65 billion by 2033, witnessing a CAGR of 16.85% during the forecast period 2023-2033.
The global MRD testing market is projected to reach $6.67 billion by 2033 from $1.47 billion in 2022, growing at a CAGR of 14.81% during the forecast period 2023-2033.
The global NGS market was valued at $6.76 billion in 2022 and is expected to reach $28.47 billion by 2033, growing at a CAGR of 13.97% during the forecast period 2023-2033.
The global contrast media agent and injector system market was valued at $7,634.6 million in 2022 and is expected to reach $9,712.3 million by 2026, growing at a CAGR of 6.20% during the forecast period 2022-2026.
The global colorectal cancer screening and diagnostic market was valued at $15.28 billion in 2022 and is expected to reach $28.52 billion by 2033, growing at a CAGR of 5.93% during the forecast period 2023-2033.
The global constrained peptide drugs market is expected to reach $17.38 billion in 2040 from $0.06 billion in 2024, growing at a CAGR of 38.94% during the forecast period 2025-2040.
The global single-cell multi-omics market is projected to reach $7.72 billion by 2033 from $1.43 billion in 2022, growing at a CAGR of 17.27% during the forecast period 2023-2033.
The global NGS data storage market is projected to reach $6.96 billion by 2033 from $1.13 billion in 2022, growing at a CAGR of 18.02% during the forecast period 2023-2033.
In 2022, the global functional genomics market was valued at $10.57 billion, and it is expected to reach $46.24 billion by 2033, growing at a CAGR of 14.04% during the forecast period 2023-2033.
The global next-generation breast cancer diagnostic and screening market was valued at $3,137.4 million in 2022 and is anticipated to reach $9,880.1 million by 2032.
A monthly review of how COVID-19 is impacting the diagnostics, therapeutics, and vaccines market. Overall, more than 225 treatment options were reported in April 2023.
The global gene editing technologies market was valued at $1.81 billion in 2022 and is anticipated to reach $16.37 billion by 2032, witnessing a CAGR of 27.50% during the forecast period 2023-2032.
In 2022, the global organ transplant diagnostics market was valued at $4.03 billion and is expected to reach $11.78 billion by 2033, with a CAGR of 10.45% during the forecast period 2023-2033.
The global cell-based assay market is expected to reach $38.23 billion in 2032 from $17.20 billion in 2022, at a CAGR of 8.44% during the forecast period 2023-2032.
The global multicancer screening market is projected to reach $7.78 billion by 2032 from $1.90 billion in 2022, growing at a CAGR of 15.09% during the forecast period 2023-2032.
The global nucleic acid therapeutics CDMO market was valued at $3.88 billion in 2022 and is expected to reach $14.19 billion by 2033, growing at a CAGR of 12.55% during the forecast period 2023-2033.
The global minimally invasive spine technologies market was valued at $3,180.9 million in 2022 and is anticipated to reach $9,406.5 million by 2032, witnessing a CAGR of 11.45% during the forecast period 2022-2032.
The Asia-Pacific and Middle East NGS market was valued at $1,055.6 million in 2022 and is anticipated to reach $2,370.7 million by 2027, witnessing a CAGR of 17.56% during the forecast period 2022-2027.
The global artificial intelligence/machine learning medical device market was valued at $4,011.7 million in 2022 and is anticipated to reach $35,458.2 million by 2032, witnessing a CAGR of 24.35% during the forecast period 2022-2032.
The global deep venous disease treatment devices market was valued at $1,119.3 million in 2022 and is anticipated to reach $2,419.2 million by 2032, witnessing a CAGR of 7.72% during the forecast period 2023-2032.
The global dry X-Ray film market was valued at $924.7 million in 2022 and is anticipated to reach $1,112.2 million by 2032, witnessing a CAGR of 1.86% during the forecast period 2022-2032.
The global AI-enabled medical imaging solutions market was valued at $1,854.5 million in 2022 and is anticipated to reach $18,356.5 million by 2032, witnessing a CAGR of 25.76% during the forecast period 2022-2032.
The global surgical robotics market was valued at $8,705.3 million in 2022 and is anticipated to reach $18,410.9 million by 2032, witnessing a CAGR of 7.78% during the forecast period 2022-2032.
The global cell and gene therapy biomanufacturing market was valued at $12.31 billion in 2022 and is anticipated to reach $29.76 billion by 2031, witnessing a CAGR of 10.31% during the forecast period 2022-2031.
The global medical X-Ray detectors market was valued at $2,167.0 million in 2022 and is anticipated to grow to $3,702.0 million by the end of 2032, at a projected CAGR of 5.50% during the forecast period 2022-2032.
The U.S. DTC wellness testing market is projected to reach $4,946.3 million by 2032 from $878.9 million in 2022, at a CAGR of 18.86% during the forecast period 2022-2032.
The U.S. orthopedic imaging modalities market was valued at $2,697.8 million in 2022 and is anticipated to grow to $3,989.9 million by the end of 2031, at a projected CAGR of 4.44% during the forecast period 2022-2031.
The global targeted sequencing market is projected to reach $10,976.1 million by 2032 from $3,198.8 million in 2022, growing at a CAGR of 13.12% during the forecast period 2022-2032.
The global nucleic acid sample preparation market is projected to reach $11,200.5 million by 2032 from $4,213.0 million in 2022, growing at a CAGR of 10.27% during the forecast period 2022-2032.
The U.S. women health laboratory testing market was valued at $72.8 billion in 2021 and is anticipated to reach $106.8 billion by 2030, witnessing a CAGR of 4.30% during the forecast period 2022-2030.
The global NGS informatics market was valued at $1,380.0 million in 2021 and is projected to reach $6,715.0 million by the end of 2032.
The U.S. prostate cancer testing market is anticipated to reach $1,901.6 million in 2030 from $544.1 million in 2021, with a CAGR of 14.7%, during the forecast period 2022-2030.
In 2021, the global prostate cancer testing market was valued at $5,246.9 million, and it is expected to reach $21,306.9 million by 2032, growing at a CAGR of 13.68% during the forecast period 2022-2032.
The global wearable patches market was valued at $8,650.0 million in 2021 and is projected to reach $26,892.7 million by the end of 2031.
The global radiation dose management market was valued at $212.8 million in 2021 and is anticipated to reach $586.7 million by 2032, witnessing a CAGR of 10.30% during the forecast period 2022-2032.
The report focuses solely on the extensive stage small cell lung cancer treatment, which includes approved products as well as products under clinical development.
The global molecular oncology diagnostics market was valued at $3,620.6 million in 2021 and is anticipated to reach $12,130.5 million by 2032, witnessing a CAGR of 11.43% during the forecast period 2022-2032.
The U.S. hereditary genetic testing market was valued at $7.57 billion in 2021 and is forecasted to reach $29.28 billion by 2032.
The global flow cytometry in oncology and immunology market was valued at $1,653.2 million in 2021 and is anticipated to reach $5,287.4 million by 2032, witnessing a CAGR of 11.39% during the forecast period 2022-2032.
The global laboratory informatics market was valued at $4,341.2 million in 2021 and is anticipated to reach $12,677.0 million by 2032, witnessing a CAGR of 10.27% during the forecast period 2022-2032.
In 2021, the global NGS kits market was valued at $4,553.6 million, and it is expected to reach $26,057.4 million by 2032, growing at a CAGR of 17.27% during the forecast period 2022-2032.
The Middle East and North Africa laparoscopy devices market was valued at $752.0 million in 2021 and is anticipated to reach $1,731.4 million by 2031, witnessing a CAGR of 7.71% during the forecast period 2022-2031.
The Canada laparoscopy devices market was valued at $392.1 million in 2021 and is anticipated to reach $865.6 million by 2031, witnessing a CAGR of 7.31% during the forecast period 2022-2031.
The global ambulatory surgical center operating room integration systems market is projected to reach $5,668.2 million by 2032 from $2,077.5 million in 2021, at a CAGR of 9.88% during the forecast period 2022-2032.
The global phosphoramidite market is projected to reach $2,062.9 million by 2032 from $900.3 million in 2021, at a CAGR of 7.78% during the forecast period 2022-2032.
In 2021, the global 3D protein structure analysis market was valued at $1,017.2 million, and it is expected to reach $2,676.6 million by 2032, growing at a CAGR of 9.32% during the forecast period 2022-2032.
The global market for serum-free media was valued at $1,022.4 million in 2021 and is expected to reach $3,920.5 million by 2032, registering a CAGR of 12.73% during the forecast period 2022-2032.
The global gastrointestinal endoscopy market was valued at $13.40 billion in 2021 and is anticipated to reach $25.75 billion by 2031, witnessing a CAGR of 6.24% during the forecast period 2022-2031.
In 2021, the global NGS library preparation automation market was valued at $1,273.2 million, and it is expected to reach $3,803.3 million by 2029, growing at a CAGR of 14.85% during the forecast period 2022-2029.
The report provides an exhaustive list of pipeline products which are currently in the development along with their developmental details in various indications.
The global cell-free RNA isolation and extraction kits market is projected to reach $140.7 million by 2032 from $30.2 million in 2021, growing at a CAGR of 14.98% during the forecast period 2022-2032.
The market size of MR imaging in neurosurgery was valued at $88.7 million in 2021 and is anticipated to reach $150.5 million by the end of 2031, registering a CAGR of 5.52% during the forecast period 2022-2031.
The global FLT3 inhibitors market is expected to reach $2,061.3 million in 2032 from $400.9 million in 2021 at a CAGR of 14.88% during the forecast period 2022-2032.
The global recombinant cell culture supplements market was estimated at $308.6 million in 2021 and is expected to reach $1,188.6 million by 2032, growing at a CAGR value of 12.24% during the forecast period 2022-2032.
The global pharmaceutical aseptic transfer market is projected to reach $2,551.5 million by 2031 from $855.2 million in 2021 at a CAGR of 9.61% during the forecast period 2022-2031.
The global digital PCR market is projected to reach $2,847.8 million by 2032 from $441.2 million in 2021, at a CAGR of 18.73% during the forecast period 2022-2032.
In 2021, the global clinical biomarkers market was valued at $21,304.3 million, and it is expected to reach $54,294.0 million by 2032, growing at a CAGR of 8.73% during the forecast period 2022-2032.
The global hyperspectral imaging market was estimated to be at $791.2 million in 2021, which is expected to grow with a CAGR of 13.17% and reach $1,640.3 million by 2027.
The global narcolepsy therapeutics market is projected to reach $4,912.3 million by 2032 from $915.2 million in 2021 at a CAGR of 15.93% during the forecast period 2022-2032.
The global human identification market is projected to reach $6,435.6 million by 2032 from $1,385.8 million in 2021, at a CAGR of 14.77% during the forecast period 2022-2032.
The global ligase market is projected to reach $651.4 million by 2032 from $371.2 million in 2021, at a CAGR of 5.29% during the forecast period 2022-2032.
The global laparoscopy and endoscopy devices market was valued at $23,809.2 million in 2021 and is projected to reach $38,942.2 million by the end of 2031, growing at a CAGR of 4.94% during the forecast period 2022-2031.
In 2021, the global microbiome therapeutics market valued $306.3 million, and it is estimated to reach $3,204 million by 2032, registering a CAGR of 24.95% during the forecast period 2022-2032.
The global NK cell therapeutics market is expected to reach $5,676.1 million in 2032 from $297.2 million in 2024 at a CAGR of 44.59% during the forecast period 2024-2032.
The global endoscopic imaging systems market was valued at $3,641.3 million in 2021 and is projected to reach $6,941.3 million by 2030.
The global NGS oncology market is projected to reach $51,783.0 million in 2032 from 14,828.6 million in 2021, witnessing a CAGR of 12.04% during the forecast period 2022-2032.
The global hematologic malignancies testing market is projected to reach $11,680.1 million by 2032, growing from $2,606.5 million in 2021, at a CAGR of 14.23% during the forecast period 2022-2032.
The global next-generation oncology devices and solutions market was valued at $3,268.2 million in 2021 and is projected to reach $5,971.3 million by 2031.
The market size of digital biomanufacturing was valued at $15,768.9 million in 2021 and is anticipated to reach $55,564.9 million by the end of 2031, registering a CAGR of 13.12% during the forecast period 2022-2031.
The minimal residual disease (MRD) testing market is projected to reach $2,611.2 million by 2027 from $1,089.3 million in 2021, at a CAGR of 14.53%.
The U.S. solid tumor testing market is projected to reach $18,287.6 million by 2032 from $9,498.8 million in 2021, at a CAGR of 6.19% during the forecast period 2022-2032.
The Middle East molecular diagnostics market is projected to reach $1,017.7 million by 2031 from $493.1 million in 2020, at a CAGR of 6.72% during the forecast period 2021-2031.
The global liquid biopsy market is projected to reach $19,066.0 million by 2032 from $2,508.2 million in 2021 at a CAGR of 19.83% during the forecast period 2022-2032.
In 2021, the Middle East liquid biopsy market was valued at $43.7 million, and it is expected to reach $175.2 million by 2032, growing at a CAGR of 13.68% during the forecast period 2022-2032.
The lung cancer genomic testing medicine market was valued at $1,262.0 million in 2020 and is expected to reach $3,279.8 million by 2031, growing at a CAGR of 8.97% during the forecast period 2021-2031.
In 2021, the Middle East precision medicine market was valued at $3,942.6 million, and it is expected to reach $8,620.0 million by 2032, growing at a CAGR of 7.37% during the forecast period 2022-2032.
In 2021, the global axial spondyloarthritis market was valued at $1,873.8, which is expected to reach $7,937.8 million in 2032 by witnessing a growing CAGR of 13.44% during the forecast period, 2022-2032.
The global blood and plasma components market is projected to reach $66.47 billion in 2031 from $39.58 billion in 2020, witnessing a CAGR of 4.90% during the forecast period 2021-2031.
The market size of digital biomarkers was valued at $1,808.3 million in 2021 and is anticipated to reach $16,174.0 million by the end of 2028, registering a CAGR of 36.06% during the forecast period 2022-2028.
In 2020, the global single cell bioinformatics software and services market was valued at $205.2 million, and it is expected to reach $634.8 million by 2031, growing at a CAGR of 10.89% during the forecast period 2021-2031.
The Europe infectious disease diagnostics market is projected to reach $7,900.4 million by 2031 from $1,394.3 million in 2020, at a CAGR of 16.48% during the forecast period 2021-2031.
The single cell RNA sequencing market is anticipated to reach a value of $2,931.3 million in 2031 from $386.7 million in 2020, witnessing a CAGR of 17.08% during the forecast period 2021-2031.
The global operating room management solutions market was valued at $2,023.5 million in 2021 and is anticipated to reach $3,699.1 million by the end of 2031, registering a CAGR of 6.29% during the forecast period 2022-2031.
The report contains the analysis of variables such as recent trends, technological advancements, and international level initiatives across the globe influencing the adoption of acellular therapy.
The global gene cloning services market was valued at $1,983.6 million in 2020 and is expected to reach $11,524.4 million by 2031, growing at a CAGR of 17.29% during the forecast period 2021-2031.
The global big data in healthcare market was valued at $32,925.1 million in 2021 and is anticipated to reach $130,132.1 million by the end of 2031, registering a CAGR of 13.96% during the forecast period 2022-2031.
The global radioligand therapy market is projected to reach $16,658.4 million by 2031, growing from $9,754.9 million in 2020, at a CAGR of 4.67% during the forecast period 2021-2031.
The report constitutes a strategical information and implementation for the plasma medicine market.
The global capillary electrophoresis market was valued at $318.3 million in 2020 and is expected to reach $586.9 million by 2031, growing at a CAGR of 5.66% during the forecast period 2021-2031.
In 2020, the global next-generation gynecological cancer diagnostics market was valued at $1,976.5 million, which is expected to reach $5,657.7 million by 2031, growing at a CAGR of 10.07% during the forecast period 2021-2031.
The global operating room (OR) integration systems market was valued at $11,763.6 million in 2021 and is projected to reach $21,546.1 million by the end of 2031.
The global oncology precision medicine market was valued at $45,174.2 million in 2020 and is expected to reach $1,28,891.6 million by 2031, growing at a CAGR of 10.05% during the forecast period 2021-2031.
The global dental radiography market was valued at $2,328.5 million in 2021 and is projected to reach $3,914.8 million by the end of 2031.
In 2020, the global hematological malignancies emerging therapeutics market was valued at $8,444.8 million, which is expected to reach $43,966.8 million in 2031.
The global minimally invasive surgical systems market is estimated to be valued at $27,882.8 million in 2020 and is anticipated to reach $55,716.7 million by the end of 2031, growing at a CAGR of 6.3% during 2021-2031.
The global precision cardiology market is projected to reach $3,584.6 million by 2031 from $956.6 million in 2020, at a CAGR of 12.90% during the forecast period 2021-2031.
The global brain disease modalities and software market was valued at $13,055.7 million in 2021 and is projected to reach $21,867.6 million by the end of 2031.
The global brain imaging modalities market was valued at $12,334.2 million in 2021 and is projected to reach $20,209.2 million by the end of 2031.
The in-silico drug discovery market is projected to reach $10,409.9 million by 2031 from $1,619.6 million in 2020, at a CAGR of 18.47% in the forecast period of 2021-2031.
The neoantigen cancer vaccine market is projected to reach $1,988.5 million by 2031 from $35.5 million in 2024, at a compound annual growth rate (CAGR) of 77.73%.
The global cell-free DNA isolation and extraction market was valued at $169.9 million in 2020 and is expected to reach $735.1 million by 2031, witnessing a CAGR of 14.19% during the forecast period 2021-2031.
The global NGS sample preparation market is projected to reach $3,279.3 million by 2026, growing from $1,468.9 million in 2020, at a CAGR of 14.24% during the forecast period 2021-2026.
The global spine X-ray and computed tomography market was valued at $916.0 million in 2020 and is projected to reach $1,623.5 million by 2030.
The global ENT devices market was valued at $13,799.5 million in 2020 and is projected to reach $25,127.7 million by 2030.
The global pharmacogenomics services market is projected to reach $9,346.8 million by 2031 from $5,060.0 million in 2020, at a CAGR of 5.71% during the forecast period 2021-2031.
The global aseptic pharma processing market was valued to be $10,633.3 million in 2020 and is expected to reach $24,364.0 million by 2031, witnessing a CAGR of 7.90% during the forecast period 2021-2031.
The global NIPT market was valued at $2.52 billion in 2020 and is expected to reach $12.61 billion by 2031, registering a CAGR of 15.79% during the forecast period 2021-2031.
The global robotic-assisted imaging technologies market was valued at $617.7 million in 2020 and is projected to reach $2,207.8 million by the end of 2030, growing at a CAGR of 13.74% during the forecast period 2021-2030.
The global viral and non-viral vector manufacturing market was valued at $1.50 billion in 2020 and is expected to reach $27.03 billion by 2031, witnessing a CAGR of 18.54% during the forecast period 2021-2031.
The global carrier screening market is projected to reach $4,479.0 million by 2031, growing from $1,187.4 million in 2020, at a CAGR of 12.67% during the forecast period 2021-2031.
The global medical grade tubing market was valued at $4,407.7 million in 2020 and is anticipated to reach $6,255.9 million by the end of 2030, witnessing a CAGR of 3.70% during the forecast period 2021-2030.
The global CRISPR gene editing market was valued at $1,088.6 million in 2020 and is expected to reach $18,856.6 million by 2031, witnessing a CAGR of 29.60% during the forecast period 2021-2031.
In 2020, the global epigenetics market was valued at $2,434.6 million, and it is expected to reach $14,311.1 million by 2031, growing at a CAGR of 17.11% during the forecast period 2021-2031.
In 2020, the global cancer microbiome sequencing market was valued at $155.5 million, and it is expected to reach $1,216.2 million by 2031, growing at a CAGR of 20.01% during the forecast period 2021-2031.
The global next-generation biomanufacturing market is expected to grow at a CAGR of 14.85% during the forecast period 2021-2031 and is expected to reach a value of $85,201.2 million in 2031.
The global preimplantation genetic testing market was valued at $972.1 million in 2020 and is expected to reach $2,725.7 million by 2031, registering a CAGR of 9.69% during the forecast period 2021-2031.
The global positive airway pressure devices market report highlights that the market was valued at $3,411.5 million in 2020 and is expected to reach $6,218.5 million by the end of 2030.
The global molecular diagnostics market is projected to reach $24,228.0 million by 2031 from $10,914.6 million in 2020, at a CAGR of 7.38% during the forecast period 2021-2031.
The global surgical microscopes market was valued at $928.3 million in 2020 and is anticipated to reach $3,578.2 million by the end of 2031, growing at a CAGR of 13.3% during the forecast period 2021-2031.
The global interventional oncology devices market was valued at $2,429.2 million in 2020 and is projected to reach $7,861.1 million by the end of 2030.
The market for Europe hereditary genetic testing is predicted to grow at a CAGR of 13.34% during the forecast period 2021-2031.
The global transcriptomics market is projected to reach $33.68 billion by 2031 from $4.47 billion in 2020, at a CAGR of 20.11% during the forecast period 2021-2031.
The global constrained peptide drugs market is anticipated to be valued at $60.1 million in 2023 and is expected to reach $10,367.2 million by 2031, witnessing a CAGR of 90.37% during the forecast period 2023-2031.
The global pharmaceutical quality management software market report highlights that the market was valued at $472.6 million in 2020 and is expected to reach $3,717.7 million by the end of 2030.
The global imaging CRO market is expected to grow at a CAGR of 7.25% during the forecast period 2021-2031 and is expected to reach a value of $9,603.0 million in 2031.
The global organ transplant diagnostics market is projected to reach $9,663.0 million by 2031, growing from $3,100.3 million in 2020, at a CAGR of 10.92% during the forecast period 2021-2031.
The global biomaterials market was valued at $122.92 billion in 2020 and is expected to reach $725.88 billion by 2031, growing at a CAGR of 17.98% between 2021 and 2031.
The global urgent care apps market was valued at $973.6 million in 2020 and is expected to reach $10,150.5 million by the end of 2030.
The global nucleic acid therapeutics CDMO market was valued at $1,546.4 million in FY2020 and is estimated to reach $4,463.7 million by 2030.
The global minimally invasive surgical systems market is estimated to be valued at $27,882.8 million in 2020 and is anticipated to reach $55,716.7 million by the end of 2031, growing at a CAGR of 6.3% during 2021-2031.
The global AI-enabled X-Ray imaging solutions market was valued to be $66.0 million in 2020 and is anticipated to reach $639.7 million by 2031, witnessing a CAGR of 20.2% during the forecast period 2021-2031.
The global ophthalmic drug delivery devices market was valued at $295.4 million in 2020 and is anticipated to reach $537.8 million by the end of 2030, witnessing a CAGR of 6.17% during the forecast period 2021-2030.
The global advanced dermatology drug delivery devices market report highlights that the market was valued at $3,348.9 million in 2020 and is expected to reach $8,783.0 million by the end of 2030.
The global gel documentation systems market is projected to reach $411.1 million by 2030 from $275.4 million in 2020, at a CAGR of 4.04% during the forecast period 2021-2030.
The global liquid handling systems market was valued to be $3,210.2 million in 2020 and is expected to reach $7,128.1 million by 2031, witnessing a CAGR of 7.43% during the forecast period 2021-2031.
The global direct-to-consumer genetic testing market accounted for $1,155.9 million in 2020 and is expected to be $6,604.5 million by 2031.
The global non-invasive liquid biopsy market is projected to reach $9,470.3 million by 2031, growing from $1,096.9 million in 2020, at a CAGR of 20.38% during the forecast period 2021-2031.
The global industrial microbiological QC market is predicted to grow at a CAGR of 5.69% over the forecast period of 2021-2031.
The global electrocardiographs market report highlights that the market was valued at $4,394.1 million in 2020 and is expected to reach $9,826.8 million by the end of 2031.
The global nutrigenomics market is set to witness a CAGR of 17.26% during the forecast period 2021-2031.
The global urology care devices and platforms market report highlights that the market was valued at $13.61 billion in 2019 and is expected to reach $33.64 billion by the end of 2030.
The radiation therapy in oncology report highlights that the market was valued at $5,481.8 million in 2020 and is expected to reach $9,206.6 million by the end of 2031.
The radiofrequency-based aesthetic devices report highlights that the market was valued at $1,052.6 million in 2020 and is expected to reach $3,204.1 million by the end of 2030.
The global market for aseptic pharma processing equipment is predicted to grow at a CAGR of 7.29% over the forecast period 2021-2030.
The nucleic acid isolation and purification market is projected to reach $5,010.3 million by 2031 from $2,304.7 million in 2020, at a CAGR of 7.20%.
The global long-read sequencing market is projected to reach $3,305.5 million by 2030 from $504.7 million in 2020, at a CAGR of 21.15% during the forecast period 2021-2030.
The global AI in operating room market was valued at $67.8 million in 2020 and is anticipated to reach $2,951.5 million by the end of 2030.
The global market for flow cytometry in oncology is predicted to grow at a CAGR of 12.02% over the forecast period 2021-2031.
The global surgical instrument tracking devices market was valued at $354.3 million in 2020 and is anticipated to reach $868.2 million by 2031.
The global AI in neurology operating room market is projected to reach $692.8 million by 2030.
The global hemodynamic monitoring devices market was valued at $867.2 million in 2018 and is projected to reach $2,156.6 million by the end of 2030.
The global haptic feedback surgical environment market is expected to grow with a CAGR of 14.6% in terms of market value, during the forecast period 2021-2031.
The global market for mRNA vaccines and therapeutics for COVID-19 vaccines is predicted to decline at a CAGR of 13.50% over the forecast period of 2021-2025.
The global reproductive genetics market is predicted to grow at a CAGR of 12.38% over the forecast period 2021-2030.
The global next-generation ultrasound systems market was valued at $8,246.8 million in 2020 and is anticipated to reach $21,079.7 million by 2031.
The market for surgical robotics generated $5.46 billion in 2020, in terms of value and is estimated to reach $16.77 billion by 2031.
The global emerging mental health devices and platforms market is projected to reach $18,717.5 million by the end of 2030, witnessing a CAGR of 24.69% during the forecast period 2021-2030.
The global hybrid operating room market was valued at $826.9 million in 2019 and is expected to reach $2,520.7 million by the end of 2030.
The global home healthcare market was valued at $130.18 billion in 2019 and is anticipated to grow to $214.98 billion by the end of 2025.
The global market for in-vitro fertilization is predicted to grow at a CAGR of 9.37% over the forecast period 2020-2030.
The global oncolytic virus therapies market is predicted to grow at a CAGR of 26.28% over the forecast period 2020-2030.
The global market for regenerative medicines is predicted to grow at a CAGR of 13.99% over the forecast period of 2020-2030.
The global solid tumor testing market is projected to reach $40,660.6 million by 2030 from $22,504.1 million in 2020, at a CAGR of 6.09% during the forecast period 2020-2030.
The global SERD therapeutics market was valued at $1000.2 million in 2019 and is expected to reach $4085.0 million by 2030.
The global market for precision psychiatry is predicted to grow at a CAGR of 17.26% over the forecast period of 2021-2026.
The global digital respiratory devices market accounted for $13.1 million in 2019 and is expected to reach $405.1 million by 2030.
The global CDSS market was valued at $1.77 billion in 2019 and is expected to reach $3.74 billion by 2030.
Global Continuous Positive Airway Pressure Market to Reach $10,182.0 Million by 2026
The global cell and gene therapy drug delivery devices market was valued at $55.75 thousand in 2019, and is expected to reach $375.13 thousand by 2030.
The global market for somatic genetic testing is predicted to grow at a CAGR of 9.30% over the forecast period of 2020-2030.
The global industrial microbiology market was valued to be $5,604.2 million in 2019 and is expected to reach $13,181.2 million by 2030.
The global wireless brain sensors market is set to witness a CAGR of 10.53% between 2021 and 2030.
The global rare disease diagnostics market has been currently witnessing a rapid growth and is expected to continue to grow at a CAGR of 8.57% during the forecast period, 2020-2030.
The global market for cell and gene therapy manufacturing QC is predicted to grow at a CAGR of 22.80% over the forecast period of 2020-2030.
The global minimally invasive gastrointestinal surgical systems market was valued at $5,021.8 million in 2020 and is anticipated to reach $10,441.0 million by 2031.
The global AI in healthcare market is anticipated to reach $35,892.2 million by 2030, registering a CAGR of 24.40%, during the forecast period 2021-2030.
The global cell and gene therapy market was valued at $2,599.7 million in 2020, and it is expected to grow at an impressive double-digit rate of 33.82% and reach a value of $25,002.1 million in 2027.
The global single-cell multi-omics market is projected to reach $3,188.9 million by 2025 from $1,221.5 million in 2020, at a CAGR of 21.16% during the forecast period, 2020-2025.
The global CRISPR gene editing market was valued at $846.2 million in 2019 and is expected to reach $10,825.1 million by 2030.
The global market for Genomic data analysis and interpretation is predicted to grow at a CAGR of 10.21% over the forecast period of 2020-2030.
The radiation dose management market is expected to grow at a CAGR of 10.96% during the forecast period, 2021-2030.
The global market for radiofrequency-based devices is predicted to grow at a CAGR of 12.81% over the forecast period of 2021-2030.
The global 4K medical imaging market was valued at $822.1 million in 2019 and is anticipated to reach $2,399.9 million by 2030, growing at a CAGR of 12.2% during the forecast period 2020-2030.
The global single-use/disposable endoscopy market was estimated to be $471.7 million in FY2019, and it is expected to grow at a CAGR of 44.03% during the forecast period, 2021-2030.
The global market for MRD testing is predicted to grow at a CAGR of 15.64% over the forecast period of 2020-2025.
The global AI-enabled medical imaging solutions market was valued at $636.1 million in 2019 and is anticipated to reach $10,145.1 million by 2030, growing at a CAGR of 26.69%, during the forecast period 2020-2030.
The global market for microbiome therapeutics is predicted to grow at a CAGR of 25.64% over the forecast period of 2020-2030.
The global oncology precision medicine market was valued at $46.90 billion in 2019, and it is expected to grow at an impressive double-digit rate of 11.21% and reach a value of $148.66 billion in 2030.
The global bioengineered skin substitutes market was valued at $1.31 billion in 2019 and is expected to reach $4.33 billion by 2030.
The global market for CAR T-cell therapy is predicted to grow at a CAGR of 44.79% over the forecast period 2020-2030.
The spatial genomics and transcriptomics market to be one of the most rapidly evolving markets, which is predicted to grow at a CAGR of 23.20% during the forecast period of 2020-2030.
The overall market was $5,681.1 million in FY2019, and it is expected to grow at a CAGR of 6.17% during the forecast period, 2021-2030.
The global digital surgery technologies market was valued at $252.5 million in 2019 and is anticipated to reach $5,110.5 million by 2030, growing at a CAGR of 32.1% during the forecast period 2020-2030.
The global advanced balloon catheter market was estimated to be $2,523.9 million in FY2019, and it is expected to grow at a CAGR of 6.25% during the forecast period, 2021-2030.
The global market for autoimmune disorder drug delivery devices is predicted to grow at a CAGR of 15.25% over the forecast period of 2020-2030.
The global minimally invasive neurosurgical systems market was valued at $419.8 million in 2019 and is anticipated to reach $1,217.4 million by 2030, growing at a CAGR of 11.9% during the forecast period 2020-2030.
The global market for COVID-19 diagnostic testing is predicted to grow at a CQGR of 23.50% over the forecast period of 3Q2020-4Q2021.
The global femtech market was valued at $560.5 million in 2018 and is expected to be valued at $4,692.3 million, by the end of 2030.
The global non-oncology precision medicine market was valued at $41.1 billion in 2019, and it is expected to grow at an impressive double-digit rate of 11.03% and reach a value of $129.96 billion in 2030.
The global market for neurodegenerative disorder therapeutics is predicted to grow at a CAGR of 7.21% over the forecast period of 2020-2030.